First Trust Advisors
TVTX icon

First Trust Advisors’s Travere Therapeutics TVTX Stock Holding History

First Trust Advisors’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
286,478
+17,929
+7% +$795K 0.01% 1005
2026
Q1 		$7.98M Sell
268,549
-73,175
-21% -$2.19M 0.01% 1205
2025
Q4 		$13.1M Buy
341,724
+169,294
+98% +$5.5M 0.01% 1005
2025
Q3 		$4.12M Sell
172,430
-66,615
-28% -$1.25M ﹤0.01% 1477
2025
Q2 		$3.54M Buy
+239,045
New +$3.96M ﹤0.01% 1542
2023
Q3 		– Sell
-13,577
Closed -$209K – 2491
2023
Q2 		$209K Buy
+13,577
New +$247K ﹤0.01% 2290
2023
Q1 		– Sell
-72,743
Closed -$1.53M – 2477
2022
Q4 		$1.53M Sell
72,743
-34,122
-32% -$723K ﹤0.01% 1815
2022
Q3 		$2.63M Buy
106,865
+57,491
+116% +$1.49M ﹤0.01% 1560
2022
Q2 		$1.2M Buy
+49,374
New +$1.24M ﹤0.01% 1919
2021
Q3 		– Sell
-22,761
Closed -$332K – 2637
2021
Q2 		$332K Sell
22,761
-90,087
-80% -$1.78M ﹤0.01% 2357
2021
Q1 		$2.82M Buy
112,848
+67,424
+148% +$1.86M ﹤0.01% 1587
2020
Q4 		$1.24M Buy
+45,424
New +$1.06M ﹤0.01% 1809
2019
Q2 		– Sell
-48,227
Closed -$1.09M – 2501
2019
Q1 		$1.09M Sell
48,227
-18,807
-28% -$416K ﹤0.01% 1828
2018
Q4 		$1.52M Sell
67,034
-93,844
-58% -$2.33M ﹤0.01% 1619
2018
Q3 		$4.62M Buy
160,878
+91,513
+132% +$2.62M 0.01% 1189
2018
Q2 		$1.89M Buy
+69,365
New +$1.85M ﹤0.01% 1652

Other funds holding TVTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

First Trust Advisors's TVTX Position: Q2 2026 in Review

First Trust Advisors increased its Travere Therapeutics (TVTX) stake by 6.7% in Q2 2026, buying an estimated $795K and bringing the position to 286,478 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #1005.

First Trust Advisors first reported a position in TVTX in Q2 2018 and has held it in 16 quarters since. 229 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • First Trust Advisors held 286,478 shares of Travere Therapeutics worth $16.3M as of Q2 2026.
  • First Trust Advisors bought 17,929 Travere Therapeutics shares in Q2 2026, an estimated $795K.
  • Travere Therapeutics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1005 holding.
  • First Trust Advisors first reported a position in Travere Therapeutics in Q2 2018 and has held it in 16 quarters since.
  • 229 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.